MDS and Compendia offer cancer therapy technology
Guest ContributorApril 30, 2009
MDS Pharma Services is collaborating with Compendia Bioscience Inc, Ann Arbor MI to help identify cancer patient populations most likely to respond to new or existing cancer therapy. MDS will provide high-throughput cellular drug profiling, combined with Compendia's 30,000 curated genomic profiles and analysis software….
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.